David J. Vance

937 total citations
46 papers, 685 citations indexed

About

David J. Vance is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, David J. Vance has authored 46 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Immunology, 25 papers in Biotechnology and 10 papers in Molecular Biology. Recurrent topics in David J. Vance's work include Toxin Mechanisms and Immunotoxins (32 papers), Transgenic Plants and Applications (25 papers) and Vector-borne infectious diseases (9 papers). David J. Vance is often cited by papers focused on Toxin Mechanisms and Immunotoxins (32 papers), Transgenic Plants and Applications (25 papers) and Vector-borne infectious diseases (9 papers). David J. Vance collaborates with scholars based in United States, Russia and Czechia. David J. Vance's co-authors include Nicholas J. Mantis, Ravi S. Kane, Charles B. Shoemaker, Amit Joshi, Yinghui Rong, M. Rudolph, Jacqueline M. Tremblay, David D. Weis, Prakash Rai and David B. Volkin and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

David J. Vance

43 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Vance United States	16	395	307	257	126	86	46	685
Yvan Boublik France	15	379 1.0×	61 0.2×	378 1.5×	76 0.6×	61 0.7×	27	914
Mahboobeh Eslami Iran	14	219 0.6×	113 0.4×	738 2.9×	263 2.1×	163 1.9×	27	928
Amanda B. Lasnik United States	11	180 0.5×	95 0.3×	194 0.8×	54 0.4×	109 1.3×	14	545
Max Hebditch United Kingdom	9	117 0.3×	89 0.3×	641 2.5×	237 1.9×	102 1.2×	12	753
Leonardo M. Damasceno United States	10	65 0.2×	161 0.5×	486 1.9×	92 0.7×	24 0.3×	13	662
Reinhard Breitling Germany	15	86 0.2×	90 0.3×	570 2.2×	58 0.5×	32 0.4×	26	834
Spyros Charonis United States	8	135 0.3×	78 0.3×	527 2.1×	171 1.4×	116 1.3×	15	671
Kanwal J. Kaur India	20	210 0.5×	83 0.3×	781 3.0×	176 1.4×	26 0.3×	43	944
Mi‐Young Kim South Korea	19	92 0.2×	310 1.0×	489 1.9×	24 0.2×	124 1.4×	54	920
Roderick Slavcev Canada	16	121 0.3×	52 0.2×	420 1.6×	172 1.4×	107 1.2×	50	755

Countries citing papers authored by David J. Vance

Since Specialization

Citations

This map shows the geographic impact of David J. Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Vance more than expected).

Fields of papers citing papers by David J. Vance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Vance. The network helps show where David J. Vance may publish in the future.

Co-authorship network of co-authors of David J. Vance

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Vance. A scholar is included among the top collaborators of David J. Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Vance. David J. Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudolph, M., David J. Vance, Carol Lyn Piazza, et al.. (2025). Germline encoded residues dominate the interaction of a human monoclonal antibody with decorin binding protein A of Borrelia burgdorferi. Frontiers in Immunology. 16. 1611828–1611828.

McCarthy, Kathleen A., Jennifer L. Yates, Karen E. Kulas, et al.. (2025). A Refined Human Linear B Cell Epitope Map of Outer Surface Protein C (OspC) From the Lyme Disease Spirochete, Borrelia burgdorferi. PubMed. 10(1). 159–186. 1 indexed citations

Vance, David J., K. F. McCarthy, Carol Lyn Piazza, et al.. (2025). A type-specific B-cell epitope at the apex of outer surface protein C (OspC) of the Lyme disease spirochete, Borreliella burgdorferi. Microbiology Spectrum. 13(4). e0288324–e0288324.

Zhao, Chenyu, Tianlin Wang, Huazhe Yang, et al.. (2023). Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment. Pharmaceutics. 15(12). 2729–2729. 16 indexed citations

Rudolph, M., Simon Davis, Monir Ejemel, et al.. (2023). Structure of a transmission blocking antibody in complex with Outer surface protein A from the Lyme disease spirochete, Borreliella burgdorferi. Proteins Structure Function and Bioinformatics. 91(11). 1463–1470. 5 indexed citations

Movahed, Elaheh, David J. Vance, Dylan Ehrbar, et al.. (2022). Serological Analysis Identifies Consequential B Cell Epitopes on the Flexible Linker and C-Terminus of Decorin Binding Protein A (DbpA) from Borrelia burgdorferi. mSphere. 7(4). e0025222–e0025222. 1 indexed citations

Vance, David J., et al.. (2020). Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies. PLoS ONE. 15(11). e0236538–e0236538. 7 indexed citations

Vance, David J., et al.. (2020). Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time. Trends in Microbiology. 29(3). 195–203. 17 indexed citations

Slyke, Greta Van, Ronald Toth, David J. Vance, et al.. (2018). Fine-Specificity Epitope Analysis Identifies Contact Points on Ricin Toxin Recognized by Protective Monoclonal Antibodies. ImmunoHorizons. 2(8). 262–273. 11 indexed citations

10.

Vance, David J.. (2016). Dermodialysis – Could sweating treatments for chronic renal failure substantially and feasibly improve outcomes in developing and even developed world contexts?. SHILAP Revista de lepidopterología. 1 indexed citations

11.

Vance, David J. & Nicholas J. Mantis. (2016). Progress and challenges associated with the development of ricin toxin subunit vaccines. Expert Review of Vaccines. 15(9). 1213–1222. 28 indexed citations

12.

Vance, David J., et al.. (2015). Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens. Clinical and Vaccine Immunology. 22(12). 1285–1293. 9 indexed citations

13.

Herrera, Cristina, David J. Vance, Leslie E. Eisele, Charles B. Shoemaker, & Nicholas J. Mantis. (2014). Differential Neutralizing Activities of a Single Domain Camelid Antibody (VHH) Specific for Ricin Toxin’s Binding Subunit (RTB). PLoS ONE. 9(6). e99788–e99788. 13 indexed citations

14.

Rudolph, M., David J. Vance, Jonah Cheung, et al.. (2014). Crystal Structures of Ricin Toxin's Enzymatic Subunit (RTA) in Complex with Neutralizing and Non-Neutralizing Single-Chain Antibodies. Journal of Molecular Biology. 426(17). 3057–3068. 38 indexed citations

15.

Vance, David J., Yinghui Rong, Robert N. Brey, & Nicholas J. Mantis. (2014). Combination of two candidate subunit vaccine antigens elicits protective immunity to ricin and anthrax toxin in mice. Vaccine. 33(3). 417–421. 11 indexed citations

16.

Iyer, Vidyashankara, Lei Hu, David J. Vance, et al.. (2013). Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine. Human Vaccines & Immunotherapeutics. 9(11). 2362–2370. 8 indexed citations

17.

Vance, David J., Jacqueline M. Tremblay, Nicholas J. Mantis, & Charles B. Shoemaker. (2013). Stepwise Engineering of Heterodimeric Single Domain Camelid VHH Antibodies That Passively Protect Mice from Ricin Toxin. Journal of Biological Chemistry. 288(51). 36538–36547. 66 indexed citations

18.

Vance, David J. & Nicholas J. Mantis. (2012). Resolution of two overlapping neutralizing B cell epitopes within a solvent exposed, immunodominant α-helix in ricin toxin's enzymatic subunit. Toxicon. 60(5). 874–877. 28 indexed citations

19.

Vance, David J., et al.. (2009). The design of polyvalent scaffolds for targeted delivery☆. Advanced Drug Delivery Reviews. 61(11). 931–939. 35 indexed citations

20.

Rai, Prakash, David J. Vance, Vincent Kwok‐Man Poon, Jeremy Mogridge, & Ravi S. Kane. (2008). Stable and Potent Polyvalent Anthrax Toxin Inhibitors: Raft‐Inspired Domain Formation in Liposomes that Contain PEGylated Lipids. Chemistry - A European Journal. 14(26). 7748–7751. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact